Literature DB >> 15853925

New mathematical methods in pharmacokinetic modeling.

Mária Durisová1, Ladislav Dedík.   

Abstract

In recent years, several new methods for the mathematical modeling have gradually emerged in pharmacokinetics, and the development of pharmacokinetic models based on these methods has become one of the most rapidly growing and exciting application-oriented sub-disciplines of the mathematical modeling. The goals of our MiniReview are twofold: i) to briefly outline fundamental ideas of some new modeling methods that have not been widely utilized in pharmacokinetics as yet, i.e. the methods based on the following concepts: linear time-invariant dynamic system, artificial-neural-network, fuzzy-logic, and fractal; ii) to arouse the interest of pharmacological, toxicological, and pharmaceutical scientists in the given methods, by sketching some application examples which indicate the good performance and perspective of these methods in solving pharmacokinetic problems.

Mesh:

Year:  2005        PMID: 15853925     DOI: 10.1111/j.1742-7843.2005.pto_01.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  8 in total

1.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. I: conceptual and numerical issues.

Authors:  J Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

2.  Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysis.

Authors:  S H Kang; M R Poynton; K M Kim; H Lee; D H Kim; S H Lee; K S Bae; O Linares; S E Kern; G J Noh
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

3.  A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac.

Authors:  Jovan K Popović; Milica T Atanacković; Ana S Pilipović; Milan R Rapaić; Stevan Pilipović; Teodor M Atanacković
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-01-14       Impact factor: 2.745

4.  Assessment of exposure to PCB 153 from breast feeding and normal food intake in individual children using a system approach model.

Authors:  Tomáš Trnovec; Ladislav Dedík; Todd A Jusko; Kinga Lancz; Lubica Palkovičová; Anton Kočan; Eva Šovčíková; Soňa Wimmerová; Juraj Tihányi; Henrieta Patayová; Irva Hertz-Picciotto
Journal:  Chemosphere       Date:  2011-11-01       Impact factor: 7.086

5.  Pharmacokinetics of Eltrombopag in Healthy Chinese Subjects and Effect of Sex and Genetic Polymorphism on its Pharmacokinetic and Pharmacodynamic Variability.

Authors:  Jinliang Chen; Yichao Xu; Honggang Lou; Bo Jiang; Rong Shao; Dandan Yang; Yin Hu; Zourong Ruan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-03-29       Impact factor: 2.441

6.  A Simple Method for the Prediction of Human Concentration-Time Profiles and Pharmacokinetics of Antibody-Drug Conjugates (ADC) from Rats or Monkeys.

Authors:  Iftekhar Mahmood
Journal:  Antibodies (Basel)       Date:  2022-06-14

7.  Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus.

Authors:  Viliam Mojto; Zuzana Rausova; Jana Chrenova; Ladislav Dedik
Journal:  Med Biol Eng Comput       Date:  2015-11-25       Impact factor: 2.602

8.  Physiologically based structure of mean residence time.

Authors:  Mária Durišová
Journal:  ScientificWorldJournal       Date:  2012-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.